• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

更高剂量的CD34+外周血祖细胞与血液系统恶性肿瘤儿科患者异基因移植后快速获得完全供体嵌合状态及较低的复发风险相关。

Higher doses of CD34+ PBPC are associated with a rapid acquisition of full donor chimerism and lower risk of relapse after allogeneic transplantation in pediatric patients with hematological malignancies.

作者信息

Gonzalez-Vicent Marta, Diaz Miguel Angel

机构信息

Department of Pediatrics, Division of Hematopoietic Stem Cell Transplantation, Hospital Infantil Niño Jesus, Madrid, Spain.

出版信息

J Pediatr Hematol Oncol. 2011 Apr;33(3):185-9. doi: 10.1097/MPH.0b013e3181f47074.

DOI:10.1097/MPH.0b013e3181f47074
PMID:21325973
Abstract

We conducted a retrospective study assessing the predictive value of early full donor chimerism status for relapse after allogeneic peripheral blood progenitor cell transplantation in 40 children aged between 1 and 16 years (median 8) with leukemia. The only variable that had a significant influence on chimerism status in either univariate or multivariate analysis was the number of CD34 cells infused. We found that the patients who were in complete donor chimerism by day +30 had a lower probability of relapse than those who were not (14% ± 6% versus 54% ± 15%; HR, 5.24; 95% confidence interval, 2.10-43.63; P = 0.003). Mixed chimerism by day +30, absence of chronic GvHD, and advanced disease at transplantation were significant risk factors for relapse in our patients. Children who presented early complete chimerism had a probability of developing chronic graft versus host disease significantly higher than patients with mixed chimerism (P = 0.04). Therefore, the analysis of chimerism kinetic in children undergoing peripheral blood progenitor cell transplantation would permit an early identification of patients at risk of relapse and patients with high risk of developing chronic graft versus host disease.

摘要

我们进行了一项回顾性研究,评估了40名年龄在1至16岁(中位年龄8岁)的白血病儿童接受异基因外周血祖细胞移植后,早期完全供体嵌合状态对复发的预测价值。在单变量或多变量分析中,唯一对嵌合状态有显著影响的变量是输注的CD34细胞数量。我们发现,在+30天时处于完全供体嵌合状态的患者复发概率低于未处于该状态的患者(14%±6%对54%±15%;风险比,5.24;95%置信区间,2.10 - 43.63;P = 0.003)。在我们的患者中,+30天时的混合嵌合状态、无慢性移植物抗宿主病以及移植时疾病进展是复发的显著危险因素。早期出现完全嵌合的儿童发生慢性移植物抗宿主病的概率显著高于混合嵌合状态的患者(P = 0.04)。因此,对外周血祖细胞移植儿童的嵌合动力学进行分析,将有助于早期识别有复发风险的患者以及有发生慢性移植物抗宿主病高风险的患者。

相似文献

1
Higher doses of CD34+ PBPC are associated with a rapid acquisition of full donor chimerism and lower risk of relapse after allogeneic transplantation in pediatric patients with hematological malignancies.更高剂量的CD34+外周血祖细胞与血液系统恶性肿瘤儿科患者异基因移植后快速获得完全供体嵌合状态及较低的复发风险相关。
J Pediatr Hematol Oncol. 2011 Apr;33(3):185-9. doi: 10.1097/MPH.0b013e3181f47074.
2
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
3
High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.CD34+选择的外周血细胞异体移植后供体嵌合体的高频率。
Exp Hematol. 1998 May;26(5):415-20.
4
Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients.儿童患者异基因外周血造血干细胞移植后慢性移植物抗宿主病的风险评估及结局
Bone Marrow Transplant. 2004 Sep;34(5):433-8. doi: 10.1038/sj.bmt.1704589.
5
Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.非亲缘供者粒细胞集落刺激因子动员的外周血干细胞异体移植:一项回顾性分析。
Haematologica. 2000 Aug;85(8):839-47.
6
Higher CD34(+) and CD3(+) cell doses in the graft promote long-term survival, and have no impact on the incidence of severe acute or chronic graft-versus-host disease after in vivo T cell-depleted unrelated donor hematopoietic stem cell transplantation in children.移植物中较高的 CD34(+) 和 CD3(+) 细胞剂量可促进长期存活,且在儿童体内 T 细胞耗竭的无关供者造血干细胞移植后,不会影响严重急性或慢性移植物抗宿主病的发生率。
Biol Blood Marrow Transplant. 2010 Oct;16(10):1388-401. doi: 10.1016/j.bbmt.2010.04.001. Epub 2010 Apr 9.
7
Fractionated TBI correlates with less T cell mixed chimerism but increased risk of relapse compared to busulphan in patients with haematological malignancies after allogeneic stem cell transplantation.在异基因干细胞移植后的血液系统恶性肿瘤患者中,与白消安相比,分次颅脑照射(Fractionated TBI)与较低的T细胞混合嵌合率相关,但复发风险增加。
Bone Marrow Transplant. 2003 Sep;32(5):477-83. doi: 10.1038/sj.bmt.1704154.
8
T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome.T细胞去除的外周血干细胞同种异体移植联合T细胞回输治疗血液系统恶性肿瘤患者:慢性移植物抗宿主病对预后的影响
Biol Blood Marrow Transplant. 2006 Dec;12(12):1318-25. doi: 10.1016/j.bbmt.2006.08.034.
9
Mixed chimerism is frequent after allogeneic peripheral blood stem cell transplantation with positive CD34 selection, and is not reverted by low doses of donor T-cells add-back.在进行阳性CD34选择的异基因外周血干细胞移植后,混合嵌合现象很常见,并且低剂量回输供体T细胞并不能使其逆转。
Eur J Haematol. 2004 Sep;73(3):162-8. doi: 10.1111/j.1600-0609.2004.00278.x.
10
Allogeneic peripheral blood stem cell transplantation with CD34+-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study.成人中采用CD34+细胞选择及延迟性T细胞回输的异基因外周血干细胞移植。一项单中心前瞻性研究的结果
Haematologica. 2000 Nov;85(11):1165-71.

引用本文的文献

1
Protective factors, management and prognosis of mixed chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia in children.儿童重型再生障碍性贫血异基因造血干细胞移植后混合嵌合体的保护因素、管理及预后
Bone Marrow Transplant. 2025 Apr 6. doi: 10.1038/s41409-025-02577-3.
2
Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease.异基因造血干细胞移植后第 14 天外周血嵌合状态对非恶性疾病治疗结果的影响。
J Korean Med Sci. 2019 Jan 29;34(6):e46. doi: 10.3346/jkms.2019.34.e46. eCollection 2019 Feb 18.
3
Impact of CD34+ cell dose in children who receive unrelated PBSCT with in vivo T-cell depletion for hematologic malignancies.
接受体内T细胞去除的无关供者外周血干细胞移植治疗血液系统恶性肿瘤的儿童中CD34+细胞剂量的影响
Bone Marrow Transplant. 2015 Jan;50(1):68-73. doi: 10.1038/bmt.2014.202. Epub 2014 Sep 29.
4
Clinical implications of chimerism after allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases.非恶性疾病儿童异基因造血干细胞移植后嵌合现象的临床意义
Korean J Hematol. 2011 Dec;46(4):258-64. doi: 10.5045/kjh.2011.46.4.258. Epub 2011 Dec 27.